Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Not listed Phase 3 Interventional

PANVAC™-VF Vaccine for the Treatment of Metastatic Pancreatic Cancer After Failing a Gemcitabine-Containing Regimen

ClinicalTrials.gov ID: NCT00088660

Public ClinicalTrials.gov record NCT00088660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 13, 2026, 6:02 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Controlled Study to Evaluate the Safety and Efficacy of PANVAC™-VF in Combination With GM-CSF Versus Best Supportive Care or Palliative Chemotherapy in Patients With Metastatic (Stage IV) Adenocarcinoma of the Pancreas Who Have Failed a Gemcitabine-Containing Chemotherapy Regimen

Study identification

NCT ID
NCT00088660
Recruitment status
Not listed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Therion Biologics Corporation
Industry
Enrollment
250 participants

Conditions and interventions

Interventions

  • PANVAC™-VF Biological

Biological

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 31, 2004
Primary completion
Not listed
Completion
Not listed
Last update posted
Feb 7, 2006

Started 2004

United States locations

U.S. sites
62
U.S. states
31
U.S. cities
55
Facility City State ZIP Site status
University of South Alabama/ Cancer Research Institute Mobile Alabama 36693
Moores UCSD Cancer Center La Jolla California 92093
Pacific Shores Medical Group Long Beach California 90813
USC/Norris Comprehensive Cancer Center Los Angeles California 90033
Chao Family Comprehensice Cancer Center Orange California 92868
Desert Hematology Oncology Medical Group, Inc Rancho Mirage California 92270
Scripps Cancer Center San Diego California 92121
VA San Diego Healthcare System San Diego California 92161
University of Colorado Health Science Center Aurora Colorado 80045
Greeley Medical Clinic Greeley Colorado 80631
Loveland Hematology Oncology Loveland Colorado 80538
Norwalk Hospital/ Whittingham Cancer Center Norwalk Connecticut 06856
Lombardi Comprehensive Cancer Center Washington D.C. District of Columbia 20007
Washington Hospital Cancer Center Washington D.C. District of Columbia 20010
Jupiter Medical Center Jupiter Florida 33458
VA Medical Center Miami Florida 33125
Jackson Memorial Hospital Miami Florida 33136
Sylvester Cancer Center Miami Florida 33136
St. Luke's Mountain States Tumor Institute Boise Idaho 83712
North Idaho Cancer Center Coeur d'Alene Idaho 83814
Carle Cancer Center Urbana Illinois 61801
Oncology Associates Cedar Rapids Iowa 52403
University of Kentucky Lexington Kentucky 40536
Hematology Oncology Life Center Alexandria Louisiana 71301
Medical Oncology, LLC Baton Rouge Louisiana 70809
Jayne Gurtler, MD and Laura Brinz, MD APMC Metairie Louisiana 70006
Tulane Cancer Center New Orleans Louisiana 70112
Maine Center for Cancer Medicine and Blood Disorders Scarborough Maine 04074
Franklin Square Hospital Baltimore Maryland 21237
Tufts-New England Medical Center, The Neeley Center for Clinical Research Boston Massachusetts 02111
Josephine Ford Cancer Center Detroit Michigan 48202
Kansas City Cancer Center Kansas City Missouri 64111
Saint Louis University Cancer Center St Louis Missouri 63110
Washington University School of Medicine St Louis Missouri 63110
Great Falls Clinic, LLP Great Falls Montana 59405
Nebraska Methodist Hospital Omaha Nebraska 68114
Dartmouth Hitchcock Medical Center Lebanon New Hampshire 03756
The Cancer Institute of New Jersey New Brunswick New Jersey 08901
New York Oncology Hematology Albany New York 12208
Winthrop Oncology/Hematology Division Mineola New York 11501
Columbia Presbyterian Medical Center New York New York 10032
Duke University Medical Center Durham North Carolina 27710
Gabrail Cancer Center Canton Ohio 44718
Hematology Oncology Consultants, Inc. Columbus Ohio 43235
Dayton Oncology Hematology Kettering Ohio 45409
University of Oklahoma Health Science Center Oklahoma City Oklahoma 73104
Temple University Cancer Center Philadelphia Pennsylvania 19140
Charleston Hematology Oncology Charleston South Carolina 29403
Charleston Cancer Center Charleston South Carolina 29406
Cancer Centers of the Carolinas Greenville South Carolina 29605
The Sarah Cannon Cancer Center Nashville Tennessee 37203
Arlington Cancer Center Arlington Texas 76012
Mary Crowley Medical Research Center Dallas Texas 75246
Texas Cancer Care Fort Worth Texas 76104
Dr. H. Alejandro Preti, F.A.C.P. Houston Texas 77030
Elkins Pancreas Center Houston Texas 77030
Tyler Cancer Center Tyler Texas 75702
Texas Cancer Care Weatherford Texas 76086
Virginia Cancer Institute Richmond Virginia 23220
Swedish Cancer Institute Seattle Washington 98104
Cancer Care Northwest Spokane Washington 99218
Medical Consultants Ltd. Milwaukee Wisconsin 53215

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00088660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Feb 7, 2006 · Synced May 13, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00088660 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →